As of Feb 21
| +0.05 / +0.07%|
The 9 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 92.00, with a high estimate of 146.00 and a low estimate of 68.00. The median estimate represents a +37.11% increase from the last price of 67.10.
The current consensus among 9 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.